Lykan Bioscience Announces Opening of SMART Manufacturing(TM) Facility
Hopkinton, MA, September 17, 2020—At its ribbon cutting celebration, Lykan Bioscience, a cell-based
therapies contract Manufacturing Services Organization (MSO) is pleased to announce the grand
opening of our 64,000 square foot SMART ManufacturingTM Facility located in Hopkinton, MA.
Tuesday’s ceremony was attended virtually by the Honorable Karyn Polito, Lt. Governor of
Massachusetts, who congratulated and thanked the company for its achievement and contribution to
the Life Sciences industry in the Commonwealth, and in person by
The company was also presented with two Massachusetts State Citations of Congratulation and
Appreciation by Susan Nicholl, District Liaison from the Office of Senate President Karen E. Spilka and
State Representative Carolyn C. Dykema.
Lykan will continue to feature its offerings, meeting virtually with potential clients and participating in
conferences such as the Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa, and
Hanson Wade’s Allogeneic Cell Therapies Summit.
About Lykan Bioscience
Formed in early 2019, Lykan Bioscience is a privately held Manufacturing Services OrganizationTM
(MSO) located in Hopkinton, MA.
With decades of biopharmaceutical industry experience in facility design, quality operations, and
engineering, Lykan Bioscience provides the first true end-to-end solution for cell-based therapies.
Lykan Bioscience offers a purpose-built facility that has been uniquely designed to fully integrate CGMP
principles and advanced software solutions.
Developed with our clients in mind, our proprietary software application platform allows for timely access
to data, logistics, and expertise in driving treatments from clinical production through to commercial
Lykan Bioscience and our clients are Transforming the Future TogetherTM, as we work collaboratively
to provide new life-saving therapies to patients worldwide. For further information, please visit
“Lykan’s new facility will supply advanced therapy medicines for thousands of patients with unmet needs
in the areas of oncology, immunology, hematology and other diseases of genetic origin,” says Lykan
Bioscience CEO Anthony Rotunno. “We are filling a significant demand for production capacity to supply
both clinical trials and commercially approved therapies. The purposely designed SMART
ManufacturingTM Facility will feature integrated data management systems and other features enabling
high-throughput to further enhance patient access.”
President of Membership from MassBio, local officials including Brendan Tedstone, Chair of the
Hopkinton Select Board, Cristina Morrissiey, President of the Hopkinton Chamber of Commerce, and
Windrose Health Investors as well as many others who have contributed to the successful launch.